Skip to content

Toggle navigation

About Us
Science & Platform
- What is Immune Tolerance?
- Our Approach
Pipeline
- Overview
- Assessment of KAN-101 in Celiac Disease
Investors & Media
Careers
Contact

About Us
Science & Platform
- What is Immune Tolerance?
- Our Approach
Pipeline
- Overview
- Assessment of KAN-101 in Celiac Disease
Investors & Media
Careers
Contact
Terms of Use
Privacy
Site Credits

Investors & Media

Press Releases

Press Releases

Press Releases

2021

2021
2020
2019
2018
2017
2015
2014
2012

February 23, 2021

Anokion Appoints Deborah Geraghty, Ph.D., as President and Chief Executive Officer
Read More

+1 857.320.6607
info@anokion.com

© 2021

Terms of Use
Privacy
Site Credits

© 2021